Similar articles

• Are agents affecting platelet functions clinically useful?

  Verstraete M. Verstraete M. Am J Med. 1976 Dec;61(6):897-914. doi: 10.1016/0002-9343(76)90414-9. Am J Med. 1976. PMID: 795299 Review.
• Reduction in venous thromboembolism by agents affecting platelet function.

  Salzman EW, Harris WH, DeSanctis RW. Salzman EW, et al. N Engl J Med. 1971 Jun 10;284(23):1287-92. doi: 10.1056/NEJM197106102842303. N Engl J Med. 1971. PMID: 5576438 Clinical Trial. No abstract available.
• [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].

  Ben Ismail M, Ghariani M, Jais JM. Ben Ismail M, et al. Nouv Presse Med. 1975 Mar 8;4(10):746 (2). Nouv Presse Med. 1975. PMID: 1129046 French. No abstract available.
• Prevention of early vein graft thrombosis by drugs altering platelet function.

  Clagett GP, Zelenock GB, Stanley JC, Lindenauer SM, Fry WJ. Clagett GP, et al. Surg Forum. 1973;24:253-4. Surg Forum. 1973. PMID: 4806002 No abstract available.
• [Inhibition of platelet aggregation: experimental findings and clinical prospects].

  de Gaetano G, Vermylen J, Verstraete M. de Gaetano G, et al. Nouv Rev Fr Hematol. 1971 May-Jun;11(3):339-63. Nouv Rev Fr Hematol. 1971. PMID: 4256693 Review. French. No abstract available.